"Advanced data analysis is a huge growth area, and we are overloaded with opportunities for our team to address issues to optimize operations at the study and operational stages."
"We now offer end-to-end modular technical services, encompassing both pre-clinical and clinical development of biosimilars addressing global regulatory requirements."
MANAGING DIRECTOR AND CEO, METEORIC BIOPHARMACEUTICALS
"We are looking into new ways to reap the benefits of artificial intelligence, particularly on the clinical side. On the physical side, Meteoric Biopharmaceuticals will have a new factory and lab up and running by the end of 2024, that will work on advanced fermentation processes."
"The Rio Tinto investment made was at a very favorable valuation which was less dilutive for our shareholders than a traditional financing, as well as being a considerable endorsement from one of the world’s largest mining companies."
"Dasa is the largest and highest-grade uranium deposit under development in Africa. We are excited to have started the underground development and look forward to transitioning from explorer to developer to a new uranium producer."
"We understand that transitioning from exploration to production is often fraught with danger for junior companies, so we are taking a very cautious approach. However, because so much is well known about Bralorne's minability, we believe that it is a relatively low risk endeavor."
38TH PRESIDENT, PROSPECTORS & DEVELOPERS ASSOCIATION OF CANADA (PDAC)
"We are calling for improved tax treatment of Canadian critical mineral development expenses to improve our domestic competitiveness and incentivize new mines."
Featuring insights from nearly 120 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting Peru’s window of opportunity to align with the global energy transition and copper’s increasingly critical role.